Cannabis Central: Carnage Continued On Wednesday (-6.2%) With Only 3 Stocks Advancing

Only 2 pot stocks trade above $20 with 3 trading between $10 and $20 and 32 trading between $1 and $10 at an average price of $3.42. On Wednesday the cannabis sector of 319 stocks declined 6.2% with only 3 of these 37 non-penny stocks advancing.

The total cannabis sector of 319 stocks declined 6.2% on Wednesday with only 3 of the 37 stocks that trade above $1/share advancing (i.e. non-penny), 32 stocks declining and 2 remaining unchanged in value.

Today's article identifies the 3 non-penny stocks that increased, the 13 that declined in excess of 10% (another 13 declined between 5% and 10%) and 10 of the remaining stocks that warrant mentioning. (Source  of data)

The Winners 

  1. Akerna (KERN) +5.9%
  2. Columbia (CCHW, CCHWF) +2.4%
  3. Ayr Strategies (AYRSF) +1.1%

The Biggest Losers

  1. New Age (NBEV) -15.1%
  2. Tilray (TLRY) -14.2%
  3. Acreage (ACRGF) -13.8%
  4. Neptune (NEPT) -12.9%
  5. Alcanna (LQSIF) -12.2%
  6. GrowGeneration (GRWG) -11.8%
  7. Harvest Health (HRVSF) -11.5%
  8. Cresco (CRLBF) -11.4%
  9. Curaleaf (CURLF) -11.0%
  10. Zynerba (ZYNE) -11.0%
  11. Pyxus (PYX) -10.3%
  12. Village Farms (VFF) -10.2%
  13. Greenlane (GNLN) -10.2%

Notable Mentions

  1. Hexo (HEXO) -13.9%
  2. OrganiGram (OGI) -9.5%
  3. Innovative Properties (IIPR) -9.1%
  4. Corbus (CRBP) -8.6%
  5. Aurora (ACB) -7.9%
  6. Cronos (CRON) -7.6%
  7. MediPharm (LABS) -7.6%
  8. Aphria (APHA) -6.3%
  9. Charlotte's Web (CWBHF) -6.2%
  10. Canopy Growth (CGC) -6.0%

For the record, as of today, only 2 pot stocks trade above $20/share, 3 trade between $10 and $20/share and the remaining 32 trade above $1/share at an average price of $3.42.

A picture is worth a thousand words. Below is Wednesday's pot stock sector heat map. (Click on image to enlarge)

Image

To see how the above stocks, and the others that make up the balance of non-penny pot stocks have done on a daily basis over the last 2 weeks, visit my previous articles here.

STOCKS IN THIS ARTICLE

Comments